Back to Directory
Deliver Biosciences
Greater London
Founded 2019
Targeted nanoparticles for in vivo CAR-T and gene delivery
Deliver Biosciences is a biotechnology company developing targeted nanoparticle vectors for in vivo cell and gene therapies.
Its delivery platform transports genetic payloads, including DNA and mRNA, into selected cell types using programmable targeting components. Its lead programme aims to engineer T cells inside patients to express chimeric antigen receptors for cancer immunotherapy, potentially reducing reliance on ex vivo cell manufacturing.
The company is investigating additional applications in genetic medicines through collaborations.
Company Notes
Previously Known As
ImmTune Therapies Limited (until 12 June 2023)
AKA / Aliases
Deliver Bio; ImmTune Therapies; NanoCAR
Member of